A detailed history of Massmutual Trust CO Fsb transactions in Catalent, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 201 shares of CTLT stock, worth $11,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201
Previous 159 26.42%
Holding current value
$11,909
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$56.16 - $60.96 $2,358 - $2,560
42 Added 26.42%
201 $12,000
Q2 2024

Jul 02, 2024

SELL
$53.58 - $57.02 $160 - $171
-3 Reduced 1.85%
159 $8,000
Q1 2024

Apr 09, 2024

BUY
$42.56 - $59.82 $1,319 - $1,854
31 Added 23.66%
162 $9,000
Q4 2023

Jan 03, 2024

BUY
$32.18 - $46.57 $418 - $605
13 Added 11.02%
131 $5,000
Q3 2023

Oct 03, 2023

BUY
$44.2 - $50.2 $221 - $251
5 Added 4.42%
118 $5,000
Q2 2023

Aug 01, 2023

SELL
$31.86 - $67.26 $7,327 - $15,469
-230 Reduced 67.06%
113 $4,000
Q1 2023

Apr 11, 2023

BUY
$45.44 - $74.26 $9,996 - $16,337
220 Added 178.86%
343 $22,000
Q4 2022

Jan 06, 2023

BUY
$41.39 - $81.0 $1,365 - $2,673
33 Added 36.67%
123 $6,000
Q3 2022

Oct 07, 2022

BUY
$72.36 - $113.1 $217 - $339
3 Added 3.45%
90 $7,000
Q2 2022

Jul 07, 2022

BUY
$87.2 - $114.05 $4,796 - $6,272
55 Added 171.88%
87 $9,000
Q1 2022

Apr 08, 2022

SELL
$94.19 - $124.49 $941 - $1,244
-10 Reduced 23.81%
32 $4,000
Q4 2021

Feb 09, 2022

BUY
$119.57 - $139.07 $1,554 - $1,807
13 Added 44.83%
42 $5,000
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $2,006 - $2,313
20 Added 222.22%
29 $3,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $913 - $1,127
9 New
9 $1,000
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $654 - $832
-9 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $432 - $711
9 New
9 $1,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.